LONDON--(BUSINESS WIRE)--May 13, 2018-- market research analysts forecast the to grow at a CAGR of over 7% during the period 2018-2022, according to their latest report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180513005045/en/

Technavio has published a new market research report on the global artificial insemination market from 2018-2022. (Graphic: Business Wire)

In this report, Technavio highlights the rising cases of prostate cancer as one of the key emerging trends in the global artificial insemination market. There has been a worldwide increase in number of people with prostate cancer. It is one of the common types of cancer among men. The treatment for prostate cancer generally requires the removal of the prostate gland. This can result in impaired sexual function and drop in fertility in at least half of the men who undergo this procedure.

This report is available at a USD 1,000 discount for a limited time only:

Save more with Technavio. Buy2 reports and get the third for FREE:

In this report, Technavio analysts highlight the rising prevalence of late parenthood as a key factor contributing to the growth of the :

Rising prevalence of late parenthood

One of the major factors leading to infertility in the present generation and is driving the demand for artificial insemination among couples is delayed parenthood. This led to an adverse effect on European countries and some of the Asian countries. In the past few decades, the global median age for bearing the first child has drastically increased. According to a research, more number of women in their 30s have children compared with those in their 20s. The Factors such as the growing use of contraceptives, increasing focus on higher education and career, and rising urbanization and the lifestyle changes has led to the rise in the median age of first pregnancy and led to a reduction in fertility rates, thereby necessitating the adoption of procedures such as artificial insemination.

According to a senior analyst at Technavio for , “A woman's fertility period is believed to be at its peak during her mid-20s. However, it starts to decline in her early 30s and declines further after 35 years and the of pregnancy reduces with age. The chances of conception rise significantly with artificial insemination. Understanding the procedure is easy and can be conducted at home using home insemination kits. Therefore, the rising trend of late parenthood is expected to drive market growth during the forecast period.”

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Global artificial insemination market segmentation

This market research report segments the global artificial insemination market into the following end-users, including commercial users and individual users and key regions, including the Americas, APAC, and EMEA.

Of the two major end-users, the commercial users segment held the largest market share in 2017, accounting for nearly 88% of the market. The market share for this end-user is expected to decrease by 2022. The fastest growing end-user is individual users, which will account for nearly 12% of the total market share by 2022.

The Americas was the leading region for the in 2017, accounting for a market share of nearly 41%. By 2022, APAC is expected to register the highest growth rate.

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180513005045/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH BIOTECHNOLOGY PHARMACEUTICAL BABY/MATERNITY RESEARCH OTHER SCIENCE CONSUMER SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 05/13/2018 04:51 AM/DISC: 05/13/2018 04:51 AM

http://www.businesswire.com/news/home/20180513005045/en